Board Changes
26 April 2006 - 9:31PM
UK Regulatory
RNS Number:0159C
Bespak PLC
26 April 2006
For immediate release 26 April 2006
Bespak plc
Board Changes
Bespak plc (LSE: BPK), a leader in specialty medical devices, is pleased to
announce the appointment of two new non-executive directors, Jim Dick and Chris
Banks to the Board of Bespak with immediate effect.
Jim, 53, has been President of Smith & Nephew Wound Management, and a member of
the Smith & Nephew Group Executive Committee, since 1999. Jim will retire from
Smith & Nephew plc at the end of June this year. Throughout his career Jim has
gained a large amount of experience in international business, innovation and
change management.
Chris, 56, has considerable experience of financial matters in international
growth-oriented companies. He was finance director at the BIS Group from 1985
to 1991 and finance director at cmg plc from 1992 to 2000. He is currently
senior non-executive director at Detica Group plc and The Innovation Group plc.
Bespak also announces today the resignation of Adrian Auer as a non-executive
director.
There are no other details to be disclosed under paragraph 6.F.2. of the Listing
Rules.
John Robinson, Bespak's Chairman, commented: " I would like to extend the thanks
of the Company and the Board to Adrian who has resigned due to his other
commitments. I am delighted to welcome Jim and Chris to the Board. Jim will
become a member of our Remuneration Committee in the next few months and his
healthcare industry experience will be of immense benefit to the Company. Chris
will replace Adrian as Chairman of our Audit Committee where his experience of
corporate finance will also be of immense benefit."
For further information please call:
Bespak plc
John Robinson - Chairman +44 (0) 20 7960 6320
Mark Throdahl - Chief Executive +44 (0) 20 1908 552 600
Martin Hopcroft - Group Finance Director
Buchanan Communications +44 (0) 20 7466 5000
Tim Thompson / Mark Court / Mary-Jane Johnson
Notes for Editors:
About Bespak plc
Bespak, a leader in specialty medical devices, develops delivery systems for the
pharmaceutical industry and disposable airway management products for critical
care settings. Bespak's product range includes metered dose and dry powder
inhalers, actuators, inflation valves, disposable face masks, breathing circuits
and laryngeal tubes.. The group, which has facilities in King's Lynn and Milton
Keynes in the UK and Indianapolis and Kent, Ohio in the US, is quoted on the
Official list of the London Stock Exchange (LSE: BPK). For more information,
please visit www.bespak.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOASEUFFMSMSEEL
Bespak (LSE:BPK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bespak (LSE:BPK)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bespak (London Stock Exchange): 0 recent articles
More Bespak Plc News Articles